(Q38466366)

3 September 2017

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study (English)

1 reference

3 September 2017

1 reference

1 reference

Janaki Amin

1

0 references

John Kaldor

series ordinal

4

object named as

John M Kaldor

1 reference

3 September 2017

5

Gregory J Dore

1 reference

3 September 2017

Matthew G Law

2

1 reference

PubMed ID

16962883

3 September 2017

Mark Bartlett

series ordinal

3

1 reference

PubMed ID

16962883

3 September 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

3 September 2017

1 reference

3 September 2017

368

1 reference

3 September 2017

9539

1 reference

3 September 2017

938-945

1 reference

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Natural history and prognosis of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Mortality of hepatitis B surface antigen-positive blood donors in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

The long-term course of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Chronic hepatitis B: a long-term retrospective cohort study of disease progression in Shanghai, China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Clinical course of hepatitis C virus during the first decade of infection: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

45-year follow-up of hepatitis C virus infection in healthy young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Probabilistic linkage of large public health data files

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Chronic hepatitis B virus infection and mortality from non-liver causes: results from the Haimen City cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. The Association for the Study of Liver Disease in Puglia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Estimates of chronic hepatitis B virus infection in Australia, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Epidemiology of hepatitis C virus infection in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients--frequency and correlates of use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Changing patterns in causes of death in a cohort of injecting drug users, 1980-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Decreased heroin availability in Sydney in early 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Supply control and harm reduction: lessons from the Australian heroin 'drought'

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Global epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969374-4

7 January 2021

10.1016/S0140-6736(06)69374-4

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

16962883